OFI Invest Asset Management’s Quest Diagnostics DGX Stock Holding History

OFI Invest Asset Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.82M	Buy	41,285 +35,877	+663%	+$7.04M	0.08%	149
2026 Q1	$1.06M	Buy	5,408 +1,631	+43%	+$317K	0.01%	239
2025 Q4	$655K	Buy	+3,777	New	+$688K	0.01%	250
2025 Q3	–	Sell	-609	Closed	-$93.2K	–	308
2025 Q2	$93.2K	Buy	+609	New	+$106K	﹤0.01%	246

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

MGP

M&G plc London, United Kingdom $20.1B AUM 16.62% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

OFI Invest Asset Management's DGX Position: Q2 2026 in Review

OFI Invest Asset Management increased its Quest Diagnostics (DGX) stake by 663% in Q2 2026, buying an estimated $7.04M and bringing the position to 41,285 shares worth $7.82M. The position accounts for 0.08% of the portfolio, ranked #149.

OFI Invest Asset Management first reported a position in DGX in Q2 2025 and has held it in 4 quarters since. 678 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

OFI Invest Asset Management held 41,285 shares of Quest Diagnostics worth $7.82M as of Q2 2026.
OFI Invest Asset Management bought 35,877 Quest Diagnostics shares in Q2 2026, an estimated $7.04M.
Quest Diagnostics made up 0.08% of OFI Invest Asset Management's portfolio in Q2 2026, its #149 holding.
OFI Invest Asset Management first reported a position in Quest Diagnostics in Q2 2025 and has held it in 4 quarters since.
678 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on OFI Invest Asset Management's 13F filing for Q2 2026, filed 17 Jul 2026.